728×90 Advertisement Banner
Back to A–Z Conditions
Other
Other

Sickle Cell Disease

Sickle cell disease (SCD) is an inherited blood disorder that affects hemoglobin, the protein in red blood cells that carries oxygen. In SCD, abnormal hemoglobin causes red blood cells to become rigid, sticky, and shaped like a crescent or sickle. These sickled cells can block blood flow, causing pain, organ damage, and other complications. SCD is lifelong and requires ongoing medical care, but advances in treatment have significantly improved life expectancy and quality of life for those affected.

Symptoms

Episodes of severe pain (pain crises) in bones, chest, or joints; chronic anemia causing fatigue and weakness; swelling of hands and feet (dactylitis); frequent infections; delayed growth in children; vision problems; jaundice (yellowing of eyes and skin); acute chest syndrome; stroke; and organ damage over time. Symptoms vary widely in severity and frequency from person to person.

Treatments

Treatment includes hydroxyurea to reduce sickling and pain crises, blood transfusions for severe anemia and complications, bone marrow or stem cell transplants (the only potential cure, available to eligible patients), gene therapy (recently FDA-approved), pain management during crises, antibiotics and vaccinations to prevent infections, and folic acid supplementation. Regular monitoring and comprehensive care from a hematologist are essential.

Risk Factors

Sickle cell disease is inherited in an autosomal recessive pattern. A child must inherit the sickle cell gene from both parents to have the disease. Having the sickle cell trait (one gene) does not cause the disease but can be passed to children. The condition is most common among people of African, Mediterranean, Middle Eastern, South Asian, and Hispanic/Latino descent. Family history is the primary risk factor.

Prevalence

Sickle cell disease affects approximately 100,000 people in the United States and millions worldwide. About 1 in 365 Black or African American babies are born with SCD, and about 1 in 13 are born with the sickle cell trait. Globally, an estimated 300,000 babies are born with SCD each year, with the highest prevalence in sub-Saharan Africa.